"The U.S. Food and Drug Administration today approved Diclegis (doxylamine succinate and pyridoxine hydrochloride) to treat pregnant women experiencing nausea and vomiting.
Diclegis is a delayed-release tablet intended for women who have"...
The adverse effects of HEMABATE Sterile Solution are generally transient and reversible when therapy ends. The most frequent adverse reactions observed are related to its contractile effect on smooth muscle.
In patients studied, approximately two-thirds experienced vomiting and diarrhea, approximately one-third had nausea, one-eighth had a temperature increase greater than 2° F, and one-fourteenth experienced flushing.
The pretreatment or concurrent administration of antiemetic and antidiarrheal drugs decreases considerably the very high incidence of gastrointestinal effects common with all prostaglandins used for abortion. Their use should be considered an integral part of the management of patients undergoing abortion with HEMABATE.
Of those patients experiencing a temperature elevation, approximately one-sixteenth had a clinical diagnosis of endometritis. The remaining temperature elevations returned to normal within several hours after the last injection.
Adverse effects observed during the use of HEMABATE for abortion and for hemorrhage, not all of which are clearly drug related, in decreasing order of frequency include:
|Flushing or hot flashes||Dyspnea|
|Chills or shivering||Tightness in chest|
|Muscular pain||Excessive thirst|
|Breast tenderness||Twitching eyelids|
|Eye pain||Gagging, retching|
|Dystonia||Sensation of choking|
|Injection site pain||Syncope|
|Vaso-vagal syndrome||Upper respiratory|
|Dryness of mouth||infection|
|Respiratory distress||Perforated uterus|
|Taste alterations||Chest pain|
|Urinary tract infection||Retained placental|
|Torticollis||Shortness of breath|
|Lethargy||Fullness of throat|
|Endometritis from IUCD||Uterine rupture|
The most common complications when HEMABATE was utilized for abortion requiring additional treatment after discharge from the hospital were endometritis, retained placental fragments, and excessive uterine bleeding, occurring in about one in every 50 patients.
Read the Hemabate (carboprost tromethamine) Side Effects Center for a complete guide to possible side effects
HEMABATE may augment the activity of other oxytocic agents. Concomitant use with other oxytocic agents is not recommended.
Read the Hemabate Drug Interactions Center for a complete guide to possible interactions
Last reviewed on RxList: 3/3/2014
Additional Hemabate Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Parenting and Pregnancy
Get tips for baby and you.